key: cord-0806810-sn78gyoo
authors: Raynor, Brinkley; Díaz, Elvis W.; Shinnick, Julianna; Zegarra, Edith; Monroy, Ynes; Mena, Claudia; De la Puente-León, Micaela; Levy, Michael Z.; Castillo-Neyra, Ricardo
title: The impact of the COVID-19 pandemic on rabies reemergence in Latin America: The case of Arequipa, Peru
date: 2021-05-21
journal: PLoS Negl Trop Dis
DOI: 10.1371/journal.pntd.0009414
sha: 7dd300edfdfe1adc57b5caa8e26d9734285164c9
doc_id: 806810
cord_uid: sn78gyoo

In Latin America, there has been tremendous progress towards eliminating canine rabies. Major components of rabies elimination programs leading to these successes have been constant and regular surveillance for rabid dogs and uninterrupted yearly mass dog vaccination campaigns. Unfortunately, vital measures to control COVID-19 have had the negative trade-off of jeopardizing these rabies elimination and prevention activities. We aimed to assess the effect of interrupting canine rabies surveillance and mass dog vaccination campaigns on rabies trends. We built a deterministic compartment model of dog rabies dynamics to create a conceptual framework for how different disruptions may affect rabies virus transmission. We parameterized the model for conditions found in Arequipa, Peru, a city with active rabies virus transmission. We examined our results over a range of plausible values for R(0) (1.36–2.0). Also, we prospectively evaluated surveillance data during the pandemic to detect temporal changes. Our model suggests that a decrease in canine vaccination coverage as well as decreased surveillance could lead to a sharp rise in canine rabies within months. These results were consistent over all plausible values of R(0). Surveillance data from late 2020 and early 2021 confirms that in Arequipa, Peru, rabies cases are on an increasing trajectory. The rising rabies trends in Arequipa, if indicative to the region as whole, suggest that the achievements made in Latin America towards the elimination of dog-mediated human rabies may be in jeopardy.

a1111111111 a1111111111 a1111111111 a1111111111 a1111111111

During the last decades, enormous progress has been achieved towards the elimination of canine rabies in the Americas [1] [2] [3] . By 2019, health authorities in the Americas felt that Latin America was closer than ever to achieving the elimination of human deaths by dog-mediated rabies. The Pan American Health Organization (PAHO) announced on the eve of World Rabies Day-28 September that only five human cases were reported in the region in the previous 12 months [2] . These achievements were due mainly to a coordinated regional plan that involved multi-pronged strategies and continuous activities conducted by national governments and local communities [3] . The COVID-19 pandemic caused by the SARS-CoV-2 coronavirus has disrupted these strategies and activities in Latin America and jeopardizes the elimination prospects in the whole region.

Among the different strategies to prevent human rabies around the world, the most effective is mass dog vaccination [1, 4, 5] . In most Latin American countries, the Ministries of Health, Ministries of Agriculture, or other public health agencies organize annual or biannual mass canine rabies vaccination campaigns in areas affected and unaffected by canine rabies [3] . Surveillance is also a vital component of rabies control programs [6] [7] [8] . In Latin America, since 1983, rabies control programs have included regular surveillance [3] . Importantly, rabies surveillance also activates control measures in response to the report of a suspected or confirmed rabid dog, which include broad control and prevention measures such as removal of the rabid dog, dog vaccinations, administration of post-exposure prophylaxis, and removal of exposed (bitten) dogs [9] [10] [11] [12] . Risk of SARS-CoV-2 transmission and sequential efforts to minimize that risk have presented barriers for implementation of rabies control strategies.

SARS-CoV-2 has infected more than 46.2 million people in the Americas as of February 3, 2021, and the pandemic has required an unprecedented, coordinated effort among national public health ministries [13] [14] [15] . Public health ministries have necessarily shifted their focus and resources to implementing stay-at-home orders and ramping up emergency preparedness efforts. Moreover, in Peru, veterinarians and other authorities have considered dog vaccination a high-risk activity during the pandemic or a non-essential veterinary activity (e.g. nonurgent or non-emergency care) [16] . In the case of rabies in Peru, and other Latin American countries, the yearly mass dog vaccination campaigns, the cornerstone of rabies prevention, were postponed and downsized in 2020 [17] [18] [19] [20] [21] . Surveillance and focus control efforts have also been scaled back due to the COVID-19 pandemic. Here we use a deterministic compartment model to explore the long-term effects of short-term changes to the rabies prevention protocols that have been developed and maintained over the past three decades. Specifically, we investigate how a reduction in canine vaccination coverage, decreased rabies surveillance, and decreased focus control efforts can affect canine rabies dynamics in Arequipa, Peru. We report a considerable and sudden increase in the number of rabid dogs in Arequipa, consistent with model trends, after failure to implement yearly mass dog vaccination campaigns in an area with reemergent transmission of rabies virus.

Data was collected from two sources. First, from 2015-2019, a door-to-door longitudinal survey was conducted in Arequipa, Peru to capture demographic data on the dog population and on vaccination campaign participation [22] . Second, collaborators at the Ministry of Health provided epidemic data on samples submitted to the Ministry of Health and subsequent focus control reports for the positive samples. Case counts and dates associated with cases were extracted from these data including: date of first clinical signs, date of death, date of sample submission, date of positive sample confirmation, and date of focus control activities.

We created a deterministic compartment model of canine rabies virus transmission in Arequipa, Peru. The model distributes the canine population between 4 population states-vaccinated (in yearly vaccination campaigns), susceptible, exposed (via the bite of a rabid dog) and infectious ( Figure A in S2 Appendix). Equations depicting the movement between compartments can be expressed as:

dI=dt ¼ gE À mI À aI ð3Þ

Parameters were estimated based on population means obtained from dog population surveys conducted by our group and epidemic data provided by the Ministry of Health (Table 1) . 

The COVID-19 pandemic interrupted two key rabies elimination activities: mass dog vaccination and canine rabies surveillance. The disruption of each of these activities affects several parameters in the model. Many vaccination programs around the world have been affected by scarce funds already shifted towards pandemic response and fear of being infected with the COVID-19 virus [29] . Similarly, for canine rabies in Latin America, the yearly vaccination campaigns were skipped, delayed, and diminished in multiple countries in 2020 [17] [18] [19] [20] [21] . To examine the effects of vaccination interruption in the model we changed v 1 , the instantaneous per capita vaccination rate to reflect different scenarios: meeting the regional [30] and national goal of 80% coverage [11] , a complete cancellation scenario of 0% coverage, and an intermediate effort of 58% coverage to match rates obtained previously ( Table A in S2 Appendix) [22] . Changes in city life during quarantine may also have impacted rabid dogs' survival in several ways. First, fewer people left home; in Arequipa, many rabid dogs (25%) are reported by unrelated city dwellers as opposed to dog owners [31] . Fewer people out in public compounded with increased difficulty in travel to and from health posts and disrupted health post hours led to reports of suspected rabid dogs decreasing to almost zero. Second, even if rabid dogs were reported, COVID-19 protocols disrupted rabies response teams, delaying euthanization and removal of suspected rabid dogs. Third, a decrease in vehicle traffic during the COVID-19 lockdown led to increased survival time of disoriented dogs that otherwise would have been hit by cars. Hampson et al. found that rabid dogs died of the disease in an average of 3.7 days if they were not killed [25] . Therefore, to examine the effect of increased survival time of rabid dogs due to COVID we shifted the death rate (α) from reflecting a mean survival time of 2.5 days (calculated from focus control reports) to 3.7 days (the expected survival time without focus control).

There were 214 reports of rabid dogs in the department of Arequipa from March 2015 to March 2020 out of 2,650 samples submitted over the period ( Figure B and Figure C in S2 Appendix), on average a little less than one (0.93) per week. Our model has reasonable matching to the reported case data assuming a reporting rate of 10% and an R 0 of 1.44 ( Figure B in S2 Appendix). The full dynamics (without any scaling for underreporting) can be seen in Fig  1, clearly showing the cyclic nature of immunity and transmission caused by the yearly vaccination campaigns. Population immunity provided by the yearly vaccination campaign decays quickly due to high rates of population turnover (controlled by parameters μ and θ) and loss of vaccine-provided immunity (ν 2 ) (Fig 1A) . The proportion of the population affected by rabies virus transmission is so small that it is not apparent when shown together with the susceptible and vaccinated population ( Fig 1A) . However, the isolated exposed and infectious population dynamics follow a cyclic pattern (Fig 1B) caused by the pulses of immunity and subsequent decay: waves of exposed and infected dogs rise as population immunity falls. We also examined this behavior over a select range of possible values of R 0 ( Fig 1C) and though the amplitude of peaks may change, the rising trends remain the same. The trends are consistent for the full range of possible values of R 0 from 1.36-2.0 ( Figure D in S2 Appendix) .

The effects of the disruption of mass vaccination and surveillance are displayed both as a surface plot with the full range of possible values of R 0 , and as a 2D line plot with R 0 = 1.44, representing our best estimate for Arequipa, Peru (Fig 2) . With zero dogs vaccinated in the city (due to a cancelled vaccination campaign), cases begin to grow exponentially (Fig 2C and 2F ). In the ideal case that vaccine coverage reached the 80% recommended by PAHO, the numbers of infected dogs were suppressed to nearly 0 (Fig 2A and 2D) . However, even intermediate coverage of 58% has a significant impact on suppressing the rise in infected numbers (Fig 2B and 2E ) compared to no vaccination coverage at all (Fig 2C and 2F ). The effect of decreased surveillance and subsequent focus control is postulated to result in increased rabid dog survival time from 2.5 to 3.7 days as seen in Fig 2D, 2E and 2F though incidence increases, the number of infected dogs can still be dampened by mass vaccination. The worst-case scenario, where all control activities, mass dog vaccination, surveillance, and focus control, cease, results in a marked exponential rise in rabies cases within a few months (Fig 2E) .

In Arequipa, the 2020 vaccination campaign was severely reduced, reaching a city-wide coverage of only 12.3%. Surveillance, measured by number of samples submitted to the ministry of health was also severely reduced in 2020 compared to previous years averages (Fig 3) . Under these conditions model trends predict an exponential rise in rabies cases within months, a prediction that has been unfortunately corroborated through preliminary surveillance results from December 2020 through March 2021. From November 2020 to February 2021 higher than average numbers of cases were detected despite continued reduced surveillance effort and only a small number of sample submissions compared to previous years ( Fig  3) . March 2021 had the largest number of canine rabies cases detected (14 cases) since the virus was re-introduced in 2015. Intermediate-term effects (5 years) were simulated in Fig 4, showing continued dramatically increased simulated rabies burden due to COVID-19 disruptions. Moreover, the rabies affected area has extended. From 2015 to January 2021, dog rabies cases were contained within the city of Arequipa, province of Arequipa (Fig 5) . Since February 2021, rabies has expanded within the department of Arequipa to a neighboring province; at least 7 rabid dogs have been detected in the province of Caylloma (Fig 5) .

Our model results predicted that disruptions to rabies control programs caused by the COVID-19 pandemic would substantially increase the number of cases of canine rabies with an associated increased risk of human rabies within a few months. Preliminary surveillance trends from Arequipa, Peru suggest that an increased rise in canine rabies cases is already occurring. This crisis has the potential to reverse strides towards the regional goal of zero canine-mediated human deaths of rabies by 2030 [33] . Given that COVID-19 will continue to challenge public health departments in the short-and medium-term as public health officials work to immunize populations worldwide, it is essential to create a strategy for rabies surveillance and prevention during the COVID-19 pandemic. This strategy should consider new approaches to dog vaccination that can accommodate social distancing and other COVID-19 prevention measures. New dog vaccination approaches, even with suboptimal coverage, could reduce canine rabies cases in the short term and prevent dog-mediated human rabies.

Our analysis and the sharp rise in canine rabies cases in Peru have broad implications regionally for Latin America. Our model of canine rabies in Arequipa demonstrates the effects of COVID-19 on the spread of canine rabies in a city with a medium to large human population (about 1 million), active immigration and emigration, continuous but suboptimal efforts to control rabies, and a fairly large free-roaming dog population [22, 31, 34] ; many of these characteristics are shared with other Latin American urban areas. Also, Arequipa represents an area of rabies reintroduction and rabies re-establishment [34] , both undesired and rare events. Modeling a city with these characteristics and continuous rabies virus transmission may provide insight into rabies-endemic Latin American cities during the COVID-19 pandemic and also into the risk of expansion to non-endemic neighboring cities.

In rabies-affected areas in Latin America, the COVID-19 pandemic has disrupted the multi-pronged rabies control program at several points, the full effects of which may not become apparent for several years. The first prong of rabies control programs that may be affected by COVID-19 is the rabies surveillance system. Because rabies surveillance systems rely heavily on submission of samples from dogs reported to exhibit clinical signs of rabies by the public, the absence of people leaving home to observe these dogs has caused greatly decreased reporting rates. In Arequipa, from April 2020 to September 2020, an average of 4.7 samples were submitted per month, compared to an average of 35.7 previously. We postulate that dogs may live longer and transmit rabies virus to a larger number of dogs before they die, as reflected by a decreased parameter α, the death rate due to rabies.

The second prong of rabies control in Arequipa is yearly vaccination campaigns. Due to COVID-19, the yearly dog vaccination campaign in Arequipa in 2020 was severely reduced to a coverage rate of 12.3%, and similar disruptions occurred across Latin America [17] [18] [19] [20] [21] . COVID-19 poses challenges to rabies vaccination campaigns in a few ways. First, geographic areas with high rates of canine rabies in particular need of vaccination points also tend to be areas with high rates of COVID-19 due to population density, which leads to concern for the safety of healthcare personnel and dog owners. Second, public health organizations are focusing their energy and resources on the COVID-19 crisis at hand. Diverting scarce public health resources towards a crisis is often necessary for some amount of time; however, our model suggests that reducing or postponing vaccination campaigns could have detrimental consequences on the spread of dog rabies and, ultimately, public health. The 2020 vaccination campaign in Arequipa covered only 4 districts out of 14 in the city; patchy, heterogeneous coverage likely further exasperates case surges seen from low vaccination rates [7, 22, [35] [36] [37] . Our results correspond with other studies around the world of the detrimental effects of disrupting rabies mass vaccination campaigns. A modeling study in Chad found that vaccination campaigns needed to be repeated due to imported cases [38] , another modeling study in Bali, Indonesia, simulated a rise in cases after control activities were halted [36] , and such a rise in rabies cases were observed in South Africa after vaccination campaigns were halted [39] . Even if the recommended 80% vaccination coverage goals may be unattainable, our model indicates that an intermediate (suboptimal) effort can still have a tremendous effect in curbing the rise of canine rabies.

The model presented above has many sources of uncertainty, perhaps the most significant is a likely massive underreporting of canine rabies cases leading to lack of accurate data and bias in parameterized data around which the model is constructed. Inadequate surveillance can exacerbate underreporting-a common problem in rabies-affected areas [3, 8, 34, [40] [41] [42] and lead to more cases as the virus spreads undetected. Additionally, we made several assumptions about the model parameters, that: 1) in Arequipa, 10% of canine rabies cases are detected, 2) the majority of dog bites transmitting rabies virus occur after the onset of rabies clinical signs in the biting (rabid) dog, and 3) vaccination immunity decay follows the conservative licensure estimate though the true decay rate of immunity may be slower. The COVID-19 pandemic likely has caused many changes in both human and dog behavior not captured in our model, such as varied movement and behavior patterns of humans leading to varied scavenging patterns and contact networks by dogs. Finally, our models are not intended for use in predicting exact values on specific dates but rather as tools to assess trends resulting from different control strategies.

The effects of stopping or pausing rabies prevention activities have had serious effects on cases of canine rabies, and consequently, on the risk of human rabies. This problem is not unique to rabies in Latin America; worldwide, COVID-19 is disrupting control efforts in a plethora of infectious disease programs. Already reported in the literature are flagging efforts to control measles and Hepatitis B Virus, decreased surveillance jeopardizing poliovirus eradication goals, and predicted surges in malaria and Dengue fever cases following pandemic neglect [29, [43] [44] [45] [46] [47] . Animal disease control programs including African Swine Fever and tuberculosis surveillance systems are also at risk [48] . Parallels can be drawn to other public health crises such as Ebola, where protocols to contain Ebola interrupted screening and diagnosis of malaria, tuberculosis, and HIV [49, 50] . Adequate surveillance, especially animal disease surveillance, is one essential piece of infectious disease control programs that is often neglected for more immediate emergencies [51] [52] [53] . COVID-19 has had a devastating toll on health through serious to fatal cases and economic hardships. However, the true extent of the damage caused by the pandemic may not be observed for years to decades as previously under-control diseases surge due to neglected control programs. 

Current and future tools for global canine rabies elimination

Latin America and the Caribbean on the cusp of eliminating rabies deaths. In: Pan American Health Organization / World Health Organization

Progress towards eliminating canine rabies: policies and perspectives from Latin America and the Caribbean

Rationale and support for a One Health program for canine vaccination as the most cost-effective means of controlling zoonotic rabies in endemic settings. Vaccine

Bolstering human rabies surveillance in Africa is crucial to eliminating canine-mediated rabies

Surveillance guidelines for disease elimination: A case study of canine rabies

Expert Consultation on Rabies: second report. World Health Organization

Protocolos de Vigilancia Epidemiológica Enfermedades Zoonó ticas. Gobierno de la república de Guatemala

Manual de rabia-Página inicial

Norma técnica de salud para la prevención y control de rabia humana en el Perú. Perú Ministerio de Salud

Programa de control y vigilancia de zoonosis. Gobierno autonómo del departametno de La Paz

Disease (COVID-19) pandemic-PAHO/WHO | Pan American Health Organization

COVID-19 cases by country

Director-General's opening remarks at the media briefing on COVID-19-11

Nota informativa no. 0029-2020-DPCEM-DGIESP/MINSA. MINSA; Available from: www.minsa.gob.pe

Así será la segunda jornada de vacunació n contra la rabia para perros y gatos en Antioquia

Campanha de Vacinação contra a raiva é adiada em SP por conta da Covid-19

Se suspende la Campaña de Vacunació n Antirrábica

Habana cancela campaña gratuita de vacunació n antirrá bica promovida por animalistas

Socio-spatial heterogeneity in participation in mass dog rabies vaccination campaigns

R: A language and environment for statistical computing. R Foundation for Statistical Computing

Plan de accion de la campaña de vacunacion antirabica canina 2019

Transmission Dynamics and Prospects for the Elimination of Canine Rabies

MSD Salud Animal Argentina

Productos [Internet

The construction of next-generation matrices for compartmental epidemic models

At least 80 million children under one at risk of diseases such as diphtheria, measles and polio as COVID-19 disrupts routine vaccination efforts, warn Gavi, WHO and UNICEF

Current status of human rabies transmitted by dogs in Latin America. Cad Saú de Pú blica

Spatial Association of Canine Rabies Outbreak and Ecological Urban Corridors

Plataforma Digital Georreferenciada del Estado peruano

Zero by 30: the global strategic plan to end human deaths from dog-mediated rabies by 2030

Barriers to dog rabies vaccination during an urban rabies outbreak: Qualitative findings from Arequipa

A dog rabies vaccination campaign in rural Africa: impact on the incidence of dog rabies and human dog-bite injuries

Designing Programs for Eliminating Canine Rabies from Islands: Bali, Indonesia as a Case Study

Heterogeneity in the spread and control of infectious disease: consequences for the elimination of canine rabies

A metapopulation model of dog rabies transmission

Epidemiology of human rabies in South Africa

An evaluation of Brazil's surveillance and prophylaxis of canine rabies between

Rabies in the Americas:1998-2014

Epidemiology of Urban Canine Rabies

The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection

The potential public health consequences of COVID-19 on malaria in Africa

Impact of COVID-19 Pandemic on Global Poliovirus Surveillance

The COVID-19 pandemic should not jeopardize dengue control

Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration-United States

COVID-19 is likely to impact animal health

Impact of the Ebola Epidemic on General and HIV Care in Macenta

Number 3-March 2016-Emerging Infectious Diseases journal-CDC

Sustainable Financing for Global Disease Surveillance and Response. Sustaining Global Surveillance and Response to Emerging Zoonotic Diseases

From Panic and Neglect to Investing in Health Security: Financing Pandemic Preparedness at a National Level. International Working Group on Financing Preparedness

Epidemiology of measles during the COVID-19 pandemic, a description of the surveillance data, 29 EU/EEA countries and the United Kingdom

We gratefully acknowledge the contributions of and the work done by the Gerencia Regional de Salud de Arequipa, the Red de Salud Arequipa Caylloma, the Laboratorio Referencial Regional Arequipa, and the Centro de Salud de Alto Selva Alegre. We acknowledge the work